When designing clinical trials for Huntington's disease, first ask the experts
Tuesday, April 23, 2019 - 14:20
in Health & Medicine
Progress in understanding the genetic mutation responsible for Huntington's disease (HD) and at least some molecular underpinnings of the disease has resulted in a new era of clinical testing of potential treatments. How best to design clinical trials in which HD patients are willing to participate and comply is a question faced by researchers.